参考文献/References:
[1]中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-443.[2]Feng H,Gong Z,Liang G,et al.Gumi Bao decoction regulates bone metabolism-related mRNA expression in glucocorticoidinduced osteoporosis in rats[J].Ann Palliat Med,2020,9(5):3213-3221.[3]汤志利,欧阳建江,徐鑫.补肾活血汤治疗绝经后骨质疏松症的临床效果评价[J].江西医药,2021,56(6):854-855.[4]李家德,钟永翔,陈永志,等.腰痛方颗粒联合抗骨质疏松药物治疗肝肾亏虚型老年性骨质疏松德效果[J].医学信息,2020,33(22):163-166.[5]赵海玲,周宗波,李建强,等.加味补肾活血汤联合中药熏蒸治疗骨质疏松性椎体压缩性骨折术后患者的临床观察[J].中国实验方剂学杂志,2019,25(8):95-100.[6]毛国庆,陈世洲,孙玉明,等.温肾健骨方治疗阳虚质骨质疏松症50例临床研究[J].中华中医药杂志,2020,35(6):3266-3269.[7]巩彦龙,宋敏,董万涛,等.固本增骨方治疗老年原发性骨质疏松的随机对照临床试验研究[J].中国骨质疏松杂志,2020,26(5):676-679,701.[8]顾伏龙,周斌,姜江,等.补肾健脾壮骨方治疗脾肾两虚型原发性骨质疏松症的临床研究[J].中药材,2019,42(1):216-218.[9]柴生颋,谢平金,方鸿星,等.补肾中药骨康方治疗肾阳虚型绝经后骨质疏松症疗效及对E2、 OPG及IGF-1影响[J].辽宁中医药大学学报,2018,20(7):170-173.[10]邱敏丽,谢雅,王晓红,等.骨质疏松症患者实践指南[J].中华内科杂志,2020,59(12):953-959.[11]肖勇洪,彭江云,李兆福,等.基于“阳化气,阴成形”理论探讨骨质疏松症的中医证治[J].中国中医基础医学杂志,2020,26(3):401-403.[12]张惜燕.补肾健脾活血法防治骨质疏松症的分子机制研究[D].咸阳:陕西中医药大学,2016.[13]葛继荣,王和鸣,郑洪新,等.中医药防治原发性骨质疏松症专家共识(2020)[J].中国骨质疏松杂志,2020,26(12):1717-1725.[14]陈巨鹏,黄国淳,严晓莺,等.从疏解“肝郁”谈绝经后骨质疏松症的辨治体会[J].中医药导报,2020,26(15):179-181.[15]郑秀霞,林应华,黄雯晖,等.原发性骨质疏松症中医辨证分型研究[J].中医临床研究,2019,11(25):50-52.[16]赵振霞,赵振敏,田玉慧,等.中医辨治骨质疏松症体会[J].河南中医,2015,35(7):1480-1482.[17]史馨钰,任艳玲.基于“命门学说”与“阴阳互济”探讨绝经后骨质疏松症的防治[J].中国医药导报,2019,16(25):110-113.[18]陈元川,李志强,庞坚,等.浅析石氏气血理论在骨质疏松防治中的指导意义[J].上海中医药大学学报,2018,32(1):8-10.[19]苑文超,马勇,闵文,等.黄桂成运用络病理论治疗骨质疏松经验[J].山东中医杂志,2018,37(4):310-312.[20]郑显达,陈凯.陈海鹏骨坚方治疗骨质疏松症临证经验窥探[J].风湿病与关节炎,2018,7(4):54-56.[21]段亚威,柴昊,安一方,等.从瘀论治原发性骨质疏松症[J].风湿病与关节炎,2021,10(2):55-58.[22]沈耿杨,杨志东,任辉,等.从坎卦角度探讨激素性骨质疏松症的病机及治法[J].四川中医,2015,33(8):32-34.
相似文献/References:
[1]汪钦生,邵 敏,姜 涛.绝经后妇女中骨质疏松患者血清钙磷、骨代谢指标与BMD的关系[J].医学信息,2019,32(04):1.[doi:10.3969/j.issn.1006-1959.2019.04.001]
WANG Qin-sheng,SHAO Min,JIANG Tao.Relationship between Serum Calcium,Phosphorus and Bone Metabolism Markers and BMD in Postmenopausal Women with Osteoporosis[J].Journal of Medical Information,2019,32(16):1.[doi:10.3969/j.issn.1006-1959.2019.04.001]
[2]李 红,孔令泉,吴凯南.乳腺癌相关骨质疏松症的发病机制及防治[J].医学信息,2020,33(07):36.[doi:10.3969/j.issn.1006-1959.2020.07.012]
LI Hong,KONG Ling-quan,WU Kai-nan.Pathogenesis and Prevention of Breast Cancer Associated Osteoporosis[J].Journal of Medical Information,2020,33(16):36.[doi:10.3969/j.issn.1006-1959.2020.07.012]
[3]刘 纳,李玉兰,许明芳,等.2型糖尿病临床期肾病与骨密度及骨代谢标记物的相关性研究[J].医学信息,2020,33(08):70.[doi:10.3969/j.issn.1006-1959.2020.08.023]
LIU Na,LI Yu-lan,XU Ming-fang,et al.Study on the Relationship Between Bone Mineral Density and Bone Metabolism Markers in Stage IV Nephropathy of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2020,33(16):70.[doi:10.3969/j.issn.1006-1959.2020.08.023]
[4]石耀武,陶宝琛,张宏蕾.西安地区骨质疏松症的影响因素及中医证型分布[J].医学信息,2020,33(11):136.[doi:10.3969/j.issn.1006-1959.2020.11.043]
SHI Yao-wu,TAO Bao-chen,ZHANG Hong-lei.Influencing Factors of Osteoporosis in Xi’an and Distribution of TCM Syndromes[J].Journal of Medical Information,2020,33(16):136.[doi:10.3969/j.issn.1006-1959.2020.11.043]
[5]米尔阿地力·麦麦提依明,阿卜杜萨拉木·亚克甫,沈志敏.骨质疏松对全膝关节置换术后康复的影响[J].医学信息,2021,34(09):99.[doi:10.3969/j.issn.1006-1959.2021.09.026]
Mieradili·Maimaitiyiming,Abudusalamu·Yakepu,SHEN Zhi-min.Effect of Osteoporosis on Rehabilitation After Total Knee Arthroplasty[J].Journal of Medical Information,2021,34(16):99.[doi:10.3969/j.issn.1006-1959.2021.09.026]
[6]李泽芹.降钙素联合阿仑膦酸盐治疗原发性骨质疏松症有效性评价[J].医学信息,2021,34(17):154.[doi:10.3969/j.issn.1006-1959.2021.17.041]
LI Ze-qin.Evaluation of the Effectiveness of Calcitonin Combined with Alendronate Sodium in the Treatment of Primary Osteoporosis[J].Journal of Medical Information,2021,34(16):154.[doi:10.3969/j.issn.1006-1959.2021.17.041]
[7]朱道信,罗志环,陈少健,等.唑来膦酸联合骨化三醇对骨质疏松症患者骨密度及骨代谢相关指标的影响[J].医学信息,2021,34(23):162.[doi:10.3969/j.issn.1006-1959.2021.23.049]
ZHU Dao-xin,LUO Zhi-huan,CHEN Shao-jian,et al.Effect of Zoledronic Acid Combined with Calcitriol on Bone Mineral Density and Bone Metabolism in Patients with Osteoporosis[J].Journal of Medical Information,2021,34(16):162.[doi:10.3969/j.issn.1006-1959.2021.23.049]
[8]张 宁,夏晓黎,王亚锋,等.慢性阻塞性肺疾病合并骨质疏松症危险因素的Meta分析[J].医学信息,2022,35(24):108.[doi:10.3969/j.issn.1006-1959.2022.24.020]
ZHANG Ning,XIA Xiao-li,WANG Ya-feng,et al.Meta-analysis of Risk Factors for Chronic Obstructive Pulmonary Disease Complicated with Osteoporosis[J].Journal of Medical Information,2022,35(16):108.[doi:10.3969/j.issn.1006-1959.2022.24.020]
[9]周奕良,毛国庆.基于网络药理学和分子对接技术探讨淫羊藿苷治疗骨质疏松症的作用机制[J].医学信息,2023,36(05):29.[doi:10.3969/j.issn.1006-1959.2023.05.005]
ZHOU Yi-liang,MAO Guo-qing.The Mechanism of Icariin in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking Technology[J].Journal of Medical Information,2023,36(16):29.[doi:10.3969/j.issn.1006-1959.2023.05.005]
[10]王彦金,周英杰,黄 勇.单、双侧椎弓根入路经皮椎体成形术治疗骨质疏松型椎体压缩骨折的对比研究[J].医学信息,2023,36(08):127.[doi:10.3969/j.issn.1006-1959.2023.08.027]
WANG Yan-jin,ZHOU Ying-jie,HUANG Yong,et al.Comparative Study of Unilateral and Bilateral Pedicle Approach Percutaneous Vertebroplasty in the Treatment of Osteoporotic Vertebral Compression Fractures[J].Journal of Medical Information,2023,36(16):127.[doi:10.3969/j.issn.1006-1959.2023.08.027]